Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Walop

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Progress in Food & Nutrition Science|January 1, 1991
'New data from old': epidemiology and record-linkageC I Neutel, H L Johansen, W Walop
Epidemiology and Infection|June 1, 1991
Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?P C Rowe, W Walop, H Lior, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 1, 1987
Questionnaire development: 4. Preparation for analysisW Walop, L Del Greco, L Eastridge, et al.
International Journal of Circumpolar Health|March 2, 2005
A fresh look at an old vaccine: does BCG have a role in 21st century Canada?M Dawar, M Clark, S L Deeks, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|December 1, 1989
An appraisal of pelvic ultrasound: a survey of gynecologistsD I Hammond, Z A Kotwall, W Walop, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1990
Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantationJ J Mazeron, J M Crook, G Marinello, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 16, 1999
Prescription and nonprescription drug use among at-risk community-dwelling seniors in Ottawa-CarletonW Walop, S Amos, W Dalziel, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 1, 1987
The role of the NH2-terminal portion of pro-opiomelanocortin as a biomarker for human lung cancerF Gilbert, W Walop, J S Chan, et al.
Pharmacogenetics|August 1, 1996
CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit populationM Jurima-Romet, J A Goldstein, M LeBelle, et al.
Cancer|May 1, 1990
The use of biomarkers in the prediction of survival in patients with pulmonary carcinomaW Walop, M Chrétien, N C Colman, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Progress in Food & Nutrition Science|January 1, 1991
'New data from old': epidemiology and record-linkageC I Neutel, H L Johansen, W Walop
Epidemiology and Infection|June 1, 1991
Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?P C Rowe, W Walop, H Lior, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 1, 1987
Questionnaire development: 4. Preparation for analysisW Walop, L Del Greco, L Eastridge, et al.
International Journal of Circumpolar Health|March 2, 2005
A fresh look at an old vaccine: does BCG have a role in 21st century Canada?M Dawar, M Clark, S L Deeks, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|December 1, 1989
An appraisal of pelvic ultrasound: a survey of gynecologistsD I Hammond, Z A Kotwall, W Walop, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1990
Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantationJ J Mazeron, J M Crook, G Marinello, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 16, 1999
Prescription and nonprescription drug use among at-risk community-dwelling seniors in Ottawa-CarletonW Walop, S Amos, W Dalziel, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 1, 1987
The role of the NH2-terminal portion of pro-opiomelanocortin as a biomarker for human lung cancerF Gilbert, W Walop, J S Chan, et al.
Pharmacogenetics|August 1, 1996
CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit populationM Jurima-Romet, J A Goldstein, M LeBelle, et al.
Cancer|May 1, 1990
The use of biomarkers in the prediction of survival in patients with pulmonary carcinomaW Walop, M Chrétien, N C Colman, et al.
Pageof 3